Artificial Intelligence Can Predict Retreatment Intervals in nAMD

An automated artificial intelligence (AI)-based system was approximately 70% accurate at predicting optimal retreatment intervals for anti-VEGF therapy in patients with neovascular age-related macular degeneration (nAMD), according to findings presented at the 2018 ARVO Annual Meeting.
à

Kickstarter's focus is on engaging with creative people: Perry Chen

AI ( artificial intelligence ) is one of the biggest changes. We've been dealing with how tech affects us for the past 10-20 years. But ...